ANI Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-18.4M | $-18.6M | $165.7K | $1.3M |
| FY2010 | $-40.1M | $-40.2M | $63.4K | $992.8K |
| FY2011 | $-47.9M | $-48.6M | $719.9K | $1.2M |
| FY2012 | $-137.0K | $-429.0K | $292.0K | $0 |
| FY2013 | $-5.5M | $-5.7M | $191.0K | $36.0K |
| FY2014 | $22.0M | $20.9M | $1.1M | $3.4M |
| FY2015 | $17.3M | $15.1M | $2.2M | $3.9M |
| FY2016 | $27.5M | $22.9M | $4.6M | $6.1M |
| FY2017 | $39.4M | $29.1M | $10.4M | $6.1M |
| FY2018 | $67.1M | $61.3M | $5.7M | $6.8M |
| FY2019 | $45.6M | $39.0M | $6.6M | $9.2M |
| FY2020 | $15.3M | $9.1M | $6.1M | $12.9M |
| FY2021 | $3.3M | $765.0K | $2.6M | $10.5M |
| FY2022 | $-31.2M | $-40.1M | $8.9M | $14.6M |
| FY2023 | $119.0M | $110.1M | $8.9M | $20.7M |
| FY2024 | $64.0M | $47.8M | $16.2M | $29.3M |
| FY2025 | $185.2M | $171.4M | $13.8M | $37.9M |